

Zelos Therapeutics
Biotechnology Research • Canada • 1-10 Employees
Company overview
| Headquarters | Canada |
| Phone number | +16108254547 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Employees | 1-10 |
| Socials |
Key Contact at Zelos Therapeutics
George Moonsammy
vice president, clinical development
About Zelos Therapeutics
Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors, Zelos is advancing a portfolio of product opportunities in Phase 2 and 3 with significant commercial potential into late stage clinical trials. The company is pursuing programs linked by the common mechanism of stimulating bone formation – specifically parathyroid hormone (PTH) analogs - to provide therapeutic benefit in key indications including osteoporosis, orthopedics and renal bone disease.
Zelos Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | $2,800,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Zelos Therapeutics Tech Stack
Discover the technologies and tools that power Zelos Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
Font scripts
Security
JavaScript libraries
JavaScript libraries
Miscellaneous
Programming languages
Miscellaneous
WordPress plugins
Blogs
Form builders
JavaScript libraries
Frequently asked questions
4.8
40,000 users



